Biotech

All Articles

Pfizer takes $230M hit after axing neglected DMD gene therapy

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) genetics treatment failure has blown a $230 mil...

AC Immune observes 'site' potential in Alzheimer's drug records

.After much more than 20 years of work with neurodegenerative health conditions, Swiss biotech AC Im...

GSK falls ph. 2 HPV vaccination over shortage of best-in-class possible

.GSK has actually scrapped a stage 2 human papillomavirus (HPV) vaccine coming from its pipe after m...

OS Therapies refiles $6M IPO to cash HER2 medication, preclinical ADCs

.Operating system Therapies will definitely specify on the NYSE American sell swap this morning usin...

ALX's fizzling CD47 feedback fee delivers inventory spiraling down

.ALX Oncology's phase 2 stomach cancer cells reaction rate has actually diminished. After finding it...

Ionis axes eye health condition coming from intendeds of Roche-partnered prospect after data dissatisfy

.An Additional of Ionis Pharmaceuticals' essential midphase readouts has actually disappointed assum...

Biogen's CEO stated no risky handle 2023. He's ready to be strong

.While Biogen's pharma peers are actually looking for late-stage properties along with little danger...

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Biography has actually been a biotech trying to find a pipe after it ditched its own lead po...

Biogen ignores Denali Alzheimer's collab

.Biogen has actually handed back legal rights to an early Alzheimer's disease program to Denali Ther...

Takeda faucets brand new head of US oncology organization-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of substantial management hirings, shootings as ...